HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder R&D

This article was originally published in The Rose Sheet

Executive Summary

The Estee Lauder Companies Innovation Institute opens in Shanghai, China, representing an investment in market-specific research and development in the region, firm announces Nov. 22. The 857-square-meter facility will focus on biological and physical sciences, with researchers studying "the safety and efficacy of topical botanical and synthetic materials and...the genetic basis for differences in the response of human skin to environmental stressors," company says. Institute will work with dermatologists and other research organization on "cutting edge" projects, develop local unique raw materials inspired by traditional Chinese medicine and work with the firm's global R&D group to achieve "tailor made, high quality products for the Asian consumer," firm adds. New facility is the seventh in the company's history and the second largest in Asia, according to Lauder...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013534

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel